Cargando…
Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
Autores principales: | Martínez, R, Muñoz, A, Velloso, M L, Rodríguez Montero, S, Belmonte-López, M A, Marenco, J L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007819/ http://dx.doi.org/10.1186/1479-5876-8-S1-P71 |
Ejemplares similares
-
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010) -
Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010) -
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010) -
Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008) -
Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)